HB 365 Summary

• Repeals sections 195.017 and 195.417 (RSMo) and enacts a new section 195.017 to regulate methamphetamine precursor substances including ephedrine, phenylpropanolamine, and pseudoephedrine.

• Establishes strict limits on over-the-counter sales: maximum 3.6 grams per 24-hour period and 9 grams per 30-day period for products containing ephedrine, phenylpropanolamine, or pseudoephedrine.

• Requires all packages of ephedrine, phenylpropanolamine, and pseudoephedrine products to be sold only from behind pharmacy counters by licensed pharmacists or pharmacy technicians, with purchasers required to provide government-issued photo identification and be at least 18 years old.

• Mandates electronic logging of all transactions including purchaser name, address, signature, purchase amount, date/time, and dispensing pharmacist name, with information submitted to the department according to established procedures.

• Includes exemptions for dietary supplements, herbs, or natural products containing naturally occurring ephedrine alkaloids not exceeding 15 percent of total weight, and allows manufacturers to apply for exemptions if products cannot be converted to methamphetamine.